NCEL 6-K: Secondary offering
NewcelX Ltd.
Filed with the SEC on · accession 0001213900-26-117550
NCEL filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. NewcelX Ltd. entered into definitive securities purchase agreements for a private placement financing with accredited investors, selling 471,125 common shares at $3.29 per share plus warrants to purchase up to 353,344 common shares at $3.75 per share, expecting gross proceeds of approximately $1.55… The stock moved +1.4% by the first close after the filing.
Summary of the filing
NewcelX Ltd. entered into definitive securities purchase agreements for a private placement financing with accredited investors, selling 471,125 common shares at $3.29 per share plus warrants to purchase up to 353,344 common shares at $3.75 per share, expecting gross proceeds of approximately $1.55 million. The company intends to use net proceeds primarily to advance its lead type 1 diabetes program NCEL-101, including an FDA-required toxicology study and preparations for a Phase 1/2a trial in 2027.
Key details
How NCEL stock reacted
Close before
$2.76
Nov 6, 2026
First close after
+1.45%
$2.80
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NCEL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NCEL?
Click hereFrequently asked questions
What did NCEL file with the SEC on Nov 9, 2026?
NCEL filed a 6-K (Secondary offering). NewcelX Ltd. entered into definitive securities purchase agreements for a private placement financing with accredited investors, selling 471,125 common shares at $3.29 per share plus warrants to purchase up to 353,344 common shares at $3.75 per share, expecting gross proceeds of approximately $1.55 million. The company intends to use net proceeds primarily to advance its lead type 1 diabetes program NCEL-101, including an FDA-required toxicology study and preparations for a Phase 1/2a trial in 2027.
What does a secondary offering mean for NCEL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did NCEL stock react to this filing?
NCEL closed at $2.76 before the filing and $2.80 on Nov 9, 2026 (+1.45%).
Other NCEL SEC filings
Get alerts when NCEL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days